Illumina Accounts Receivable

Illumina Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Illumina Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Illumina's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Illumina's accounts receivable are only considered to be worth 75% of book value:

Illumina's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Illumina Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Illumina's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina Business Description

Industry

Healthcare » Medical Diagnostics & Research NAICS : 621511 SIC : 8071

Comparable Companies

XSWX:LONN SHSE:603259 NYSE:IQV NAS:IDXX NYSE:A NYSE:MTD NYSE:LH NYSE:PKI XPAR:ERF NAS:ICLR

Traded in Other Exchanges

ILMN:Mexico 0J8Z:UK ILU:Germany ILU:Germany ILU:Germany I1LM34:Brazil ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Executives

Flatley Jay T	director	9885 TOWNE CENTRE DR SAN DIEGO CA 92121
Tousi Susan H	officer: SVP Product Development	5200 ILLUMINA WAY SAN DIEGO CA 92122
Reeves Kathryne Gambrell	officer: SVP, Chief Marketing Officer	5200 ILLUMINA WAY SAN DIEGO CA 92122
Goswami Joydeep	officer: SVP Corp Business Development	SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023
Dadswell Charles	officer: SVP & General Counsel	5200 ILLUMINA WAY SAN DIEGO CA 92122
Desouza Francis A	director, officer: President and CEO	350 ELLIS STREET MOUNTAIN VIEW CA 94043
Van Oene Mark	officer: SVP Chief Commercial Officer	5200 ILLUMINA WAY SAN DIEGO CA 92122
Ragusa Robert P	officer: SVP, Global Quality & Ops	PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: RAGUSA ROBERT P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Mcginnis Karen K	officer: VP, Chief Accounting Officer	INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284
Hoyt Aimee L	officer: SVP, Chief People Officer	5200 ILLUMINA WAY SAN DIEGO CA 92122
Ronaghi Mostafa	officer: SVP, Entrepreneurial Devlopmt	9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Aravanis Alexander	officer: SVP, Chief Technology Officer	5200 ILLUMINA WAY SAN DIEGO CA 92122
Siegel Susan E	director	3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025
Thompson John Wendell	director	C/O MICROSOFT CORPORATION ONE MICROSOFT WAY REDMOND WA 98053
Epstein Robert S	director	PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: EPSTEIN ROBERT S a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}